NCT03633604View on ClinicalTrials.gov

Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia

AVAILABLEEXPANDED_ACCESS

Timeline

Start Date

Not specified

Conditions

Anemia Severe

Interventions

BIOLOGICAL

HBOC-201

Intravenous administration of a hemoglobin based oxygen carrier (HBOC) in patients with life-threatening anemia, for whom allogeneic blood transfusion is not an option.

Trial Locations (1)

15213

AVAILABLE

University of Pittsburgh Medical Center, Pittsburgh